Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dual leucine zipper kinase (DLK), also known as MAP3K12, is a member of the mixed-lineage kinase (MLK) family and functions as a mitogen-activated protein kinase kinase kinase (MAPKKK). It is a serine/threonine protein kinase that regulates neuronal stress responses, axonal degeneration, and regeneration through downstream effectors like JNKs and p-c-Jun. DLK is a potential therapeutic target for preventing progressive neuronal loss in various neurological diseases.
Inhibition of DLK kinase activity to reduce neuronal degeneration
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dual Leucine Zipper Kinase (DLK).